Arsenic Trioxide Inhibits the Metastasis of Small Cell Lung Cancer by Blocking Calcineurin-Nuclear Factor of Activated T Cells (NFAT) Signaling
- 26 March 2019
- journal article
- retracted article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 25, 2228-2237
Abstract
BACKGROUND:The inhibitory effect of arsenic trioxide (As₂O₃) on lung cancer has been reported in some preclinical studies. However, its effect on small cell lung cancer (SCLC) has been poorly explored. Calcineurin and its substrate, nuclear facto...Keywords
This publication has 47 references indexed in Scilit:
- The Calcineurin-NFAT-Angiopoietin-2 Signaling Axis in Lung Endothelium Is Critical for the Establishment of Lung MetastasesCell Reports, 2013
- From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemiaBlood, 2011
- Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: Role of Akt and nuclear factor-κBCancer Letters, 2011
- Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathwayJournal of Clinical Investigation, 2011
- Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2010
- Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1Nature, 2009
- Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicityBlood, 2006
- Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapyAnnals of Oncology, 2005
- Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor κBOncogene, 2004
- The role of NFAT transcription factors in integrin-mediated carcinoma invasionNature Cell Biology, 2002